Oncology PracticeLong-term CCB therapy linked to higher breast cancer riskAugust 5, 2013Breast Cancer
Oncology PracticeAge does not impact survival in HER2-positive breast cancerJuly 30, 2013Breast Cancer
Oncology PracticeGuidelines issued on radiation-induced heart diseaseJuly 25, 2013Patient & Survivor CareBreast Cancer
Oncology PracticeStem cell mutations in breast cancer may confer metastatic riskJuly 24, 2013Breast Cancer
Oncology PracticeGenetic alterations affect everolimus benefit in breast cancerJuly 22, 2013Breast Cancer
Oncology PracticeUpamostat falls short in HER2-negative metastatic breast cancerJuly 22, 2013Breast Cancer
Oncology PracticeBOLERO 3: Everolimus may overcome trastuzumab resistance in HER2-positive breast cancerJuly 12, 2013Breast Cancer
Oncology PracticeUpdated guideline urges discussion of breast cancer chemopreventionJuly 8, 2013Breast Cancer
The Journal of Community and Supportive OncologyCancer health disparities and risk factors: lessons from a woman with a 20-cm chest wall mass, growing for 2 yearsJuly 2, 2013Breast CancerPatient & Survivor Care
Oncology PracticeBOLERO-3: Everolimus tweaks trastuzumab-resistant metastatic breast cancerJune 14, 2013Breast Cancer
Oncology PracticeSupreme Court: Human genes cannot be patented June 13, 2013Practice ManagementBreast CancerBusiness of Medicine
Oncology PracticeHow will sequestration affect American cancer care?June 7, 2013Practice ManagementBreast CancerPatient & Survivor CareBusiness of Medicine
Oncology PracticeGene mutations found in 22% of African American breast cancer patientsJune 6, 2013Breast Cancer
